Complications
. | MAT, no. children with GvHD/total no. children (%) . | RIC, no. children with GvHD/total no. children (%) . | P . |
|---|---|---|---|
| Acute GvHD less than grade 2 | 9/19 (47) | 12/33 (36) | .44 |
| Acute GvHD more than grade 2 | 2/19 (10) | 3/33 (9) | .87 |
| Limited chronic GvHD | 3/19 (16) | 0 | .02 |
| Extensive chronic GvHD | 1/19 (5) | 1/33 (39) | .69 |
| Viral reactivations | 4/19 (21) | 13/33 (39) | .02 |
| Mortality | 9/19 (47) | 2/33 (6) | <.01 |
. | MAT, no. children with GvHD/total no. children (%) . | RIC, no. children with GvHD/total no. children (%) . | P . |
|---|---|---|---|
| Acute GvHD less than grade 2 | 9/19 (47) | 12/33 (36) | .44 |
| Acute GvHD more than grade 2 | 2/19 (10) | 3/33 (9) | .87 |
| Limited chronic GvHD | 3/19 (16) | 0 | .02 |
| Extensive chronic GvHD | 1/19 (5) | 1/33 (39) | .69 |
| Viral reactivations | 4/19 (21) | 13/33 (39) | .02 |
| Mortality | 9/19 (47) | 2/33 (6) | <.01 |